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Objective: To investigate whether changing the lipid source induces metabolic changes and/or
modulates the adipose tissue distribution in mice fed with a high-fat (HF) diet.
Methods: C57BL/6 mice were subjected to a 10-wk control diet (10% fat) or an HF diet (60% fat)
containing lard (HF-L), olive oil (HF-O), sunﬂower oil, or canola oil. Food intake and body weight
were measured. At euthanasia, blood was collected and adipose tissue was dissected. Serum
hormones and cytokines were determined.
Results: The plasma insulin levels were higher in the HF-L and HF-O groups than in the other three
groups (P < 0.0001). The levels of resistin were highest in the HF-L and HF-O groups (P < 0.0001).
Leptin expression was also highest in these two groups (P < 0.0001). Of the four groups,
interleukin-6 was expressed at the highest level in the HF-L group (P < 0.0005), whereas adipo-
nectin was expressed at the lowest level (P < 0.0001). The accumulation of subcutaneous and
visceral adipose tissues was higher in the HF-L group compared with the other groups. This group
was hypertrophic because of excess subcutaneous fat and epididymal fat in the adipocytes.
However, the ratio of subcutaneous to visceral fat was signiﬁcantly lower in the HF-L and HF-O
groups compared with the other groups.
Conclusion: In mice fed fat-rich diets, the level of adipokines, the distribution of adipose tissue, and
the metabolism of carbohydrates are more signiﬁcantly inﬂuenced by the lipid content rather than
the absolute amount of lipid.
 2012 Elsevier Inc. Open access under the Elsevier OA license.Introduction
The primary role of adipose tissue was traditionally thought to
serve as a temporary storage site for energy in the form of tri-
acylglycerol, but adipose tissue is recognized currently as the
largest endocrine organ of the human body [1]. Adipose tissue
is known to express and secrete a variety of products known as
adipokines, which include leptin, adiponectin, resistin, visfatin [2,
3], vaspin [4], and omentin [5,6] in addition to proinﬂammatoryelho Nacional de Ciencia e
quisa do Estado do Rio de
ax: þ55-21-2868-8033.
sevier OA license.cytokines, such as tumor necrosis factor-a, interleukin (IL)-6, and
monocyte chemoattractant protein-1 [7].
Studies have reported that C57BL/6 mice develop obesity,
insulin resistance (IR), diabetes mellitus, hypertriglyceridemia
[8,9], advanced fatty liver, and fatty pancreatic diseases when fed
a high-fat (HF) diet (rich in saturated fat) [10], and the diseases
these mice develop closely resemble common forms of disease in
humans after developing obesity [11,12]. Compared with other
animal models, such as Zucker obese rats, ob/ob or db/db mice, or
othergene-deletionanimalmodels, theseHFdiets serve asamodel
ofexogenousobesity,whicharisesbyahigherdietarycaloric intake
(fat overload) [13]. One study has shown that C57BL/6 mice carry
a genetic trait that predisposes them to store fat when the dietary
fat content is high [12]. However, these results cannot be general-
ized to human populations, because the obesity in humans
respondsmore to a level of dietary carbohydrates and not to a level
Table 1
Experimental diets
Ingredients (g/kg) Groups
SC HF-L HF-O HF-S HF-Ca
Casein
(85% protein)
140.0 190.0 190.0 190.0 190.0
Corn starch 620.692 250.692 250.692 250.692 250.692
Sucrose 100.0 100.0 100.0 100.0 100.0
Soy oil 40.0 40.0 40.0 40.0 40.0
Lard d 320.0 d d d
Olive oil d d 320.0 d d
Sunﬂower oil d d d 320.0
Canola oil d d d d 320.0
Fiber 50.0 50.0 50.0 50.0 50.0
Vitamin mix* 10.0 10.0 10.0 10.0 10.0
Mineral mix* 35.0 35.0 35.0 35.0 35.0
Cystine 1.8 1.8 1.8 1.8 1.8
Choline 2.5 2.5 2.5 2.5 2.5
Antioxidant 0.008 0.008 0.008 0.008 0.008
Total amount (g) 1000.0 1000.0 1000.0 1000.0 1000.0
Energy (kcal/g) 3807 5407 5407 5407 5407
Carbohydrate (%) 76 26 26 26 26
Protein (%) 14 14 14 14 14
Lipid (%) 10 60 60 60 60
HF-Ca, high-fat diet with canola oil; HF-L, high-fat diet with lard; HF-O, high-fat
diet with olive oil; HF-S, high-fat diet with sunﬂower oil; SC, standard rodent
chow
* Vitamins and minerals present in the mix were in accordance with AIN-93M
speciﬁcations.
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favorable effect on themetabolic syndrome thana low-fatdiet [14].
This can be explained by the metabolic adaptations induced by
carbohydrate restriction [15] and less stimulation of insulin. Lower
insulin levels result in increased lipolysis and fatty acid oxidation
and simultaneously decreases the activity of key enzymes in de
novo lipogenesis [16]. To conﬁrm this, one work studied over-
weight but otherwise healthy women with normal lipid proﬁles
[14]. In this population, the results of this study demonstrated that
a short-term, hypocaloric, very low-carbohydrate, and low-fat diet
had a similar effect on cardiovascular risk as shown by similar
changes in the ratio of total cholesterol to high-density lipoprotein
cholesterol and fasting and postprandial triacylglycerol levels.
However, a very low-carbohydrate diet was more effective than
a low-fat diet at improving insulin sensitivity as measured by the
homeostasis model assessment (HOMA) using fasting glucose and
insulin levels, but the signiﬁcance of this small decrease probably
was not physiologically relevant in glucose clearance or insulin
effectiveness [14].
In rats, an HF diet not only accelerates the ﬁlling of pre-
existing adipocytes but also stimulates the proliferation of
adipocyte precursor cells [17]. Therefore, the hypothesis that
obesity may be evaluated as an endocrine tumor has been
approached from a genetic perspective in considering hyper-
plasia and hypertrophy of adipocytes, neovascularization, and
increased functional activity in obesity [18].
An indicator for metabolic alterations is the “regional distri-
bution of adipose tissue.” Obesity is not a homogeneous condi-
tion, and the regional distribution of adipose tissue is important
for understanding the relation among obesity, glucose metabo-
lism, and lipid metabolism [19]. Although an increase in total
adiposity promotes a higher risk of metabolic diseases, visceral
adipose tissue is more closely related to obesity-associated
pathologies and complications compared with total adiposity
or the quantity of subcutaneous adipose tissue [20,21].
This study was undertaken to increase the understanding of
the effect of speciﬁc lipid sources from HF diets on glucose
metabolism, the distribution of adipose tissue, and the structure
and secretory functions in C57BL/6 mice.Materials and methods
Animals and diets
All procedureswere performed in accordancewith the guidelines of the animal
ethics committee at the State University of Rio de Janeiro and were conducted in
accordance with the conventional guidelines for experimentation with animals
(National Institutes of Health Publication No. 85-23, revised 1996). Animals were
maintained under controlled conditions (21  2C, humidity 60  10%, and 12-h
dark/12-h light cycle). Male C57BL/6 mice (12 wk old) were randomly divided
into ﬁve groups (n ¼ 15 per group, total 75) and subjected to different dietary
regimens (Table 1): the standard rodent chow (SC group; 10% of energy from fat,
3.8 kcal/g of chow) or an HF diet (60% of energy from fat, 5.4 kcal/g of chow) con-
taining lard (HF-L group), olive oil (HF-O group), sunﬂower oil (HS-O group), or
canola oil (HF-Ca group). The diets were manufactured by PragSolucoes (PragSo-
lucoes, Jau, SP, Brazil; http://www.pragsolucoes.com.br) in accordancewithAIN-93
recommendations [22]. Diets were administered over a 10-wk period.Body mass, food intake, and feed efﬁciency
Mice had free access to food and water during the experimental period, and
their intakes were monitored daily. In addition, their body mass was measured
each week. Fresh chow was provided daily, and any remaining chow from the
previous day was discarded. Food consumptionwas determined as the difference
between the food supplied and the amount of food left in the grid. Energy intake
was the product of food consumption by the energy content of the diet. Feed
efﬁciency was calculated as the ratio between the body mass gain in grams and
the food consumed in kilojoules per animal, multiplied by 100.Blood analysis
A blood glucose test, an oral glucose tolerance test (OGTT), and an intra-
peritoneal insulin tolerance test (IPITT) were conducted before the initiation of
the diet feeding and after 9 wk of diet feeding. For blood glucose levels, bloodwas
obtained by milking the tail after a small incision was made to the animal’s tail
(Accu-Chek glucometer, Roche Diagnostic, Manheim, Germany). The OGTT was
performed using a 25% solution of glucose in sterile saline (0.9% NaCl) at a dose of
1.0 g/kg. The glucose was administered by orogastric gavage after a 6-h fasting
period. The blood glucose concentration was measured before glucose admin-
istration (0 min) and 15, 30, 60, and 120 min after administration. For the IPITT,
fasting blood glucose levels were measured (after a 4-h fasting period, blood
obtained from the tail vein) using a glucometer (Accu-Chek; 0 min). Insulin was
subsequently injected intraperitoneally (1.0 U/kg) and blood glucose was
measured again at 15, 30, 60, and 120 min.
On the day before euthanasia, animals were deprived of food for 6 h before
being anesthetized (intraperitoneal sodium pentobarbital 150 mg/kg), after
which blood samples were obtained by cardiac puncture through the right
atrium. The blood plasma was obtained by centrifugation (120  g, 15 min) at
room temperature. Serum adipokines, inﬂammatory cytokines, and insulin were
measured using Multiplex Biomarker Immunoassays for Luminex xMAP tech-
nology (Millipore, Billerica, MA, USA). The leptin, resistin, IL-6, monocyte che-
moattractant protein-1, plasminogen activator inhibitor type 1, tumor necrosis
factor-a, and insulin levels were assessed by MADPK-71K, and adiponectin levels
were measured using SinglePlex adiponectin kits (mouse, EZMADP-60K). The
HOMA-IR was calculated as fasting glucose (millimoles per liter) multiplied by
the fasting insulin level (microunits per milliliter) divided by 22.5 [23].Adipose tissue
The subcutaneous fat between the lower part of the rib cage and the mid-
thigh was considered inguinal fat, whereas the fat connected to the posterior
abdominal wall in the vicinity of the kidneys and the abdominal portion of the
ureters was considered retroperitoneal fat. The abdominal fat in the lower part of
the abdomen and connected to the epididymis was considered epididymal fat.
Therefore, after the animals were euthanized, the inguinal (subcutaneous),
epididymal, retroperitoneal, and perirenal fat pads were carefully dissected out
(both sides of the animal) and weighed.
The adipose tissues from the subcutaneous and epididymal depots were
ﬁxed in freshly prepared 4% (w/v) buffered formalin (pH 7.2) and embedded in
Paraplast plus (Sigma-Aldrich Co., St. Louis, MO, USA), sectioned (5 mm thick), and
stained with hematoxylin and eosin. Digital images were obtained from the
histologic sections and at least 500 adipocytes per group were randomly
analyzed. The cell diameters weremeasured by imaging analysis using Image-Pro
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estimated as the weight of the visceral plus subcutaneous fat pads multiplied by
100 and then divided by the total body mass [24].
Data analyses
The resulting data were tested for normality and homogeneity of variances
and then comparisons among groups were performed using one-way analysis of
variance and the Tukey post hoc test. Correlations were assessed using the
Pearson correlation test to investigate correlations among fat masses, adipokines,
resistin, leptin, and adiponectin plasma levels. The differences within the same
group as a function of timewere analyzed using the paired t test (GraphPad Prism
5.03, GraphPad Software, La Jolla, CA, USA). P  0.05 was considered statistically
signiﬁcant.
Results
Food intake and feed efﬁciency
Food intakewasnot different among the four groups. However,
the feed efﬁciency inmice receiving theHF-Ldietwas signiﬁcantly
higher compared with the other three groups (þ64%, P < 0.01).
Therewere no statistically signiﬁcant differences among the three
other groups (HF-O, HF-S, and HF-Ca) in feed efﬁciency (Table 2).
Body mass
All animals started the experiment with similar body masses.
Lard feeding induced a signiﬁcant body mass gain in the HF-L
mice that was observed at week 6, and this gain continued
until the end of the experimental period, resulting in the greatest
body mass among the four experimental groups. The HF-L group
had a ﬁnal body mass that was 18% greater than the SC control
group and 15% greater than the other three experimental groups
(P < 0.001; Fig. 1).Table 2
Various lipid sources induce different responses in mice fed high-fat diets
Data Groups
SC HF-L
Dietetic
Food intake (g) 2.7  0.3 2.8  0.1
Feed efﬁciency (103; g/kcal) 5.5  1.0 9.0  1.3a
Carbohydrate metabolism
Baseline glucose (mg/dL) 132.0  8.5 158.2  9.8
Insulin (pg/mL) 423.1  92.3 1376.0  135.1a
HOMA-IR 3.3  0.6 13.5  2.0a
Inﬂammatory cytokines
IL-6 (pg/mL) 3.2  0.6 17.6  3.8a
PAI-1 (pg/mL) 1706.0  338.2 1688.0  240.1
MCP-1 (pg/mL) 40.7  7.8 42.8  7.7
TNF-a (pg/mL) 3.6  0.8 3.9  0.4
Adipose tissue
Subcutaneous mass (g)* 0.09  0.01 0.13  0.01a
Visceral mass (g)y 0.75  0.03 1.33  0.13a
Subcutaneous/visceral fat 0.14  0.01 0.08  0.01a
Adipocyte diameter (mm)
In subcutaneous fat 57.4  4.3 79.2  4.8a
In inguinal fat 60.3  4.4 95.8  5.0a
Adipokines
Resistin (pg/mL) 357.4  52.12 990.6  85.83a
Leptin (pg/mL) 598.6  159.0 2105.0  377.5a
Adiponectin (pg/mL) 975.2  53.40 544.0  25.26a
HF-Ca, high-fat diet based on canola oil; HF-L, high-fat diet based on lard; HF-O, high
homeostasis model assessment for insulin resistance; IL-6, interleukin-6; MCP-1, mon
SC, standard rodent chow; TNF-a, tumor necrosis factor-a
Values are presented as mean  SEM. Statistical symbols (aSC group, bHF-L group, cH
* The inguinal fat pad.
y The sum of the retroperitoneal, epididymal, and perirenal fat pads.Carbohydrate metabolism
At the start of the experiment, the OGTT and IPITT measure-
ments did not show any statistically signiﬁcant difference among
the groups. However, at the end of the experiment, the blood
glucose levels and the OGTT and IPITT measurements remained
unaffected by the diets, whereas the plasma insulin levels were
increased by 225% and 156% in the HF-L and HF-O groups,
respectively, compared with the SC control group (P < 0.0001).
Moreover, the HOMA-IR indexes, which reﬂect whole-body IR,
were 309% and 209% higher in the HF-L and the HF-O groups,
respectively, compared with the SC control group (P < 0.0001).
Notably, the serum insulin levels and the HOMA-IR index were
slightly higher in the HF-S and HF-Ca groups compared with the
SC control group; however, these differences were not statisti-
cally signiﬁcant (Figs. 2, 3, Table 2).Adipokines
In agreement with the results of carbohydrate metabolism,
the levels of resistin were consistent with the results of the
HOMA-IR index (Table 2). The resistin expression levels were
177% and 86% higher in the HF-L and HF-O groups, respectively,
compared with the SC control group (P < 0.0001). Resistin levels
were 150% higher in the HF-L group and 68% higher in the HF-O
group compared with the HF-S group (P < 0.0001). The levels of
resistin were 247% and 133% higher in the HF-L and HF-O groups
compared with the HF-Ca group (P < 0.0001). The differences in
the resistin levels were not statistically signiﬁcant compared
with the HF-S, HF-Ca, and SC groups.
The HF-L and HF-O groups showed the highest levels of leptin
of all the experimental groups. The leptin levels were 252% and
358% higher in the HF-L and HF-O groups, respectively, comparedHF-O HF-S HF-Ca
3.0  0.2 3.1  0.1 3.1  0.2
5.3  1.1b 4.3  1.1b 5.4  1.1b
153.4  9.2 127.4  2.3 129.4  4.3
1082.0  69.2a 809.6  51.7b 725.3  71.5b
10.2  1.0a 6.3  0.4bc 5.8  0.7bc
5.5  0.7b 6.0  0.7b 7.8  0.6b
1474.0  132.2 1700.0  188.9 1366.0  318.5
54.2  5.9 50.2  4.3 37.1  7.1
2.9  0.3 3.0  0.2 3.7  0.1
0.05  0.01ab 0.09  0.0bc 0.08  0.0bc
0.53  0.05b 0.49  0.03b 0.57  0.05b
0.07  0.02a 0.17  0.01bc 0.14  0.01bc
59.0  3.5b 59.5  3.2b 56.0  2.7b
58.3  2.7b 60.3  2.5b 57.7  3.0b
664.8  51.70a 396.4  25.19bc 285.2  55.06bc
2742.0  337.7a 506.3  133.8bc 153.5  20.49bc
734.6  41.44ab 734.8  53.82ab 733.5  51.06ab
-fat diet based on olive oil; HF-S, high-fat diet based on sunﬂower oil; HOMA-IR,
ocyte chemoattractant protein-1; PAI-1, plasminogen activator inhibitor type 1;
F-O group) represent statistical differences at P < 0.05
Fig. 1. Body mass evolution. Starting in the sixth week, the HF-L group gained more
bodymass than the other threegroups. Thismass differencewasmaintaineduntil the
end of the experiment. The values are reported as mean  SEM. The statistical
difference among the groups is indicated by the same symbol (P< 0.01). HF-Ca, high-
fat diet basedon canola oil;HF-L, high-fat diet basedon lard;HF-O, high-fat diet based
on olive oil; HF-S, high-fat diet based on sunﬂower oil; SC, standard chow.
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levels were 316% and 442% higher in the HF-L and HF-O groups,
respectively, than in the HF-S group (P< 0.0001); compared with
theHF-Cagroup, the leptin levelswere1,272%and1,687%higher in
the HF-L and HF-O groups, respectively (P < 0.0001; Table 2).
Interestingly, the levels of adiponectin were lowest in the
HF-L group. In general, these levels were low in mice fed HF dietsFig. 2. The OGTT included the curves (left) and the bar graph for the AUCs (right). The v
groups. a.u., arbitrary unit; AUC, area under the curve; HF, high-fat diet; OGTT, oral gluccompared with mice fed standard chow (HF-L, 44% less, P <
0.001; HF-O, 25% less, P < 0.01; HF-S, 25% less, P < 0.01; HF-Ca,
25% less, P < 0.01). In the HF-L group, the levels of adiponectin
were lower than in the HF-O, HF-S, and HF-Ca groups (26% less,
P < 0.05). No statistically signiﬁcant differences were found
among the HF-O, HF-S, and HF-Ca groups (Table 2).Inﬂammatory cytokines
The IL-6 levels were the highest in the HF-L group. This level
was 450% higher than that observed in the SC group (P < 0.001),
220% higher than in the HF-O group (P < 0.01), 193% higher than
in the HF-S group (P < 0.01), and 126% higher than in the HF-Ca
group (P < 0.01). No statistically signiﬁcant difference was found
in the IL-6 levels among the SC, HF-O, HF-S, and HF-Ca groups.
The remaining inﬂammatory cytokines, plasminogen activator
inhibitor type 1, monocyte chemoattractant protein-1, and tumor
necrosis factor-a, did not change as a function of the different
diets (Table 2).Adipose tissue
The subcutaneous and visceral fat masses were greatest for
the HF-L group (Table 2, Fig. 4). The subcutaneous fat mass in the
HF-L group was 44% greater than the corresponding masses in
the SC and HF-S groups (P < 0.001). The subcutaneous fat mass
was also 160% greater than that observed in the HF-O group (P <
0.001) and 62% greater than the mass in the HF-Ca group (P <
0.001). However, the subcutaneous fat pad in the HF-O group
was 44% less than that observed in the HF-S group (P< 0.05) and
37% less than in the HF-Ca group (P < 0.05). The HF-L group also
showed the greatest visceral fat pad, which was 77% greater than
in the pad for the SC group (P < 0.001), 151% greater than in the
HF-O group (P< 0.001), 171% greater than in the HF-S group (P <
0.001), and 133% greater than in the HF-Ca group (P < 0.001). No
statistically signiﬁcant difference was observed for the masses of
the subcutaneous fat pad and visceral fat pad among the HF-S,
HF-Ca, and SC groups.
The ratio of subcutaneous to visceral fat ratio was more than
40% smaller in the HF-L and HF-O groups compared with thatalues are reported as mean  SEM. No statistical differences were found among the
ose tolerance test; SC, standard chow.
Fig. 3. The IPITT included the curves (left) and the bar graph for the AUCs (right). The values are reported as mean  SEM. No statistical differences were found among the
groups. a.u., arbitrary unit; AUC, area under the curve; HF, high-fat diet; IPITT, intraperitoneal insulin tolerance test; SC, standard chow.
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signiﬁcant differences were reported for this ratio among the SC,
HF-S, and HF-Ca groups.Fig. 4. The adipocyte diameter of the epididymal adipose tissue in (A) the group fed stand
diet based on olive oil, (D) the group fed a high-fat diet based on sunﬂower oil, and (E)The adipocytes were hypertrophic in the epididymal and
subcutaneous fat pads of the HF-L group. The epididymal
adipocyte in the HF-L group was more than 30% larger than inard chow, (B) the group fed a high-fat diet based on lard, (C) the group fed a high-fat
the group fed a high-fat diet based on canola oil.
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addition, the subcutaneous adipocytes of the HF-L group were
more than 60% larger than in the SC, HF-O, HF-S, and HF-Ca
groups (P < 0.05; Table 2, Fig. 4).
Correlation among adipokines, adipose tissue, and adiposity index
There was a signiﬁcant positive correlation between resistin
and visceral fat masses (R ¼ 0.72, P < 0.00005) and between
resistin levels and the adiposity index (R ¼ 0.72, P < 0.00006).
Interestingly, the levels of leptin and adiponectin were not
correlated with visceral or subcutaneous fat masses or with the
adiposity index.
Discussion
In the present study, the diets rich in saturated (HF-L) and
monounsaturated (HF-O) fatty acids induced IR by increasing the
level of inﬂammatory adipokines and decreasing the ratio of
subcutaneous to visceral fat, regardless of the animal’s body
mass. In contrast, diets that were rich in polyunsaturated fatty
acids (HF-S and HF-Ca) did not alter any of the factors involved in
the genesis of IR and obesity.
In the present study, the HF-L mice were heavier than the
other mice on the HF diets, but HF-L mice actually consumed the
same amount of diet per gram of body weight as the other
groups. This point is emphasized by the ﬁnding of a much higher
feed efﬁciency (weight gain divided by caloric consumption) in
HF-L mice compared with the other mice on HF diets. This means
that HF-L mice can store more fat without consuming more
calories. Therefore, total calories alone do not account for the
greater weight gain of HF-L mice, and this suggests that the body
fat gain in HF-Lmice despite the same diet intake is tightly linked
to the source of dietary lipid. The ability to store fat seems to be
more important in the development of obesity in C57BL/6 mice
than the increase in caloric content of an HF diet [12].
It has been argued that because the rate of carbohydrate and
protein oxidation is determined by intake of these nutrients,
whereas the rate of fat oxidation is determined largely by the gap
between total energy expenditure and energy intake, obesity is
the natural result of a diet rich in fat [25]. From the other studies
cited earlier, it would seem that the metabolic rate can be altered
as a consequence of altering the fatty acid proﬁle of the diet.
Some classic studies have directly addressed this possibility. In
animal studies comparing isocaloric HF diets containing satu-
rated (edible beef tallow) with u-6 fat (safﬂower oil), larger
amounts of body fat were accumulated in rats that consumed
saturated fat [26]. The expired air from the rats was trapped and
the oxygen and carbon dioxide concentrations analyzed by a gas
mass analyzer. The increased body fat was associated with lower
oxygen consumption compared with the safﬂower oil–fed
animals, indicating a decreased diet-induced thermogenesis of
the saturated fat compared with the safﬂower fat, suggesting
that the metabolic rate is altered in conjunction with the
modiﬁcation of membrane phospholipids using the dietary
intervention. Another work using open-circuit respirometry; the
rodents consuming diets with a relatively high-unsaturated fat
proﬁle had signiﬁcantly greater metabolic rates than those
consuming isocaloric high-saturated fat diets [27,28]. Thus, the
phospholipid fatty acid composition of membranes seems to be
a direct determinant of the metabolic rate in rodents. Higher
levels of saturated fatty acids in the diet affect membrane fatty
acid composition, leading to a decreased metabolic rate and thus
increased susceptibility to obesity.There are few intervention studies in humans addressing the
dietary fatty acid proﬁle and metabolic rate. Perhaps the classic
study is that by Jones and Schoeller [29]. In this 2-wk crossover
design study, consisting of two consecutive 7-d dietary treat-
ment periods, subjects consumed diets differing only in the
dietary u-6 polyunsaturated-to-saturated fatty acid ratio. The
basal metabolic rate and the thermogenic effect of food were
measured in each subject on days 1 and 7 of each diet period
using open-circuit respiratory gas exchange. Consistent with the
animal data, the more saturated diet resulted in the lowest basal
metabolic rate, thus favoring weight gain. However, that study
was limited because a high-carbohydrate diet was not compared
with an HF diet.
High-fat diet–induced obesity has been well understood for
more than a century [30]. Further studies have shown that HF
diets promote hyperglycemia and increase body mass and IR
[9,10]. Therefore, it can be used as an experimental model for
studying the metabolic syndrome of IR in rodents [31–33].
As evident from the literature, diets with varied fatty acid
composition are broadly grouped under the term high-fat diet,
even if most of the corresponding studies involved the adminis-
tration of a formulawith only oneHF component for the purposes
of comparison with standard chow and openly failed to analyze
the inﬂuence of different fat components in the model. Thus, few
studies have been performed by changing the components of
these HF diets with the goal of a subsequent assessment of their
metabolic effects.
It is generally believed that diets based on saturated fatty
acids induce the typical HF diet phenotype, whereas diets con-
taining polyunsaturated fatty acids have beneﬁcial effects on
body composition and insulin action [34,35]. However, the role
of monounsaturated fatty acids in this context is unclear. In the
present study, saturated and monounsaturated HF diets proved
effective for inducing the inﬂammation response and IR
commonly found in human metabolic syndromes.
Abnormal adipose tissue development leads to IR in non-
adipose organs. Ectopic deposition and inﬂammation play a
central role in thedevelopmentof IR in themuscle, liver, andother
tissues and establish a negative reverberating cycle [36]. There is
a correlation between the accumulation of intrahepatic and
intramuscular triacylglycerols and a low capacity to oxidize fatty
acids in the presence of IR [37–39]. This is in agreement with the
ﬁndings of the present study in the HF-L and HF-O groups that
showed IR. This effect is clearly demonstrated when saturated
fatty acids are used [9,10,40], but the data are scarce regarding the
other sources of fatty acids. A previous study [31] and the present
study have demonstrated a marked IR in mice fed saturated or
monounsaturated fatty acids, demonstrating that the lipid source
is as important as the quantity of the food consumed.
In thepresent study,weobserved that theparameters of IR and
the inﬂammatory response with the HF-L and HF-O diets led to
the most pronounced manifestations. We also observed less
subcutaneous fat mass deposition in HF-O mice compared with
controls (this difference was not seen in the visceral fat mass
deposition), but the inﬂammatory response and IR in these
animals occurred despite this smaller fat deposition. In contrast,
we observed a decrease of the ratio of subcutaneous to visceral fat
mass by 50% inHF-O andHF-Lmice. In this case, these resultsmay
suggest that the hyperinsulinemia and inﬂammatory response
are more associated with body fat distribution (ratio of subcuta-
neous to visceral fat) than with total body fat deposition. For
example, not all obese patients have the same risk of developing
diabetes, cardiovascular disease, or hyperlipidemia. Individuals
with peripheral obesity, i.e., fat distributed subcutaneously in the
M. Catta-Preta et al. / Nutrition 28 (2012) 212–219218gluteofemoral region, are at little or no risk of the common
medical complications of obesity, whereas individuals with
central obesity, i.e., fat accumulated in visceral depots, are prone
to these complications [41–43]. Furthermore, obesity occurs with
different degrees of fat accumulation in different depots, and
these are associatedwith different metabolic consequences, with
visceral accumulation of fat producing a much greater risk of
diabetes, dyslipidemia, and accelerated atherosclerosis than
subcutaneous fat and the patterns of fat distribution, and may
have a developmental genetic origin [44]. In some cases, the
metabolic consequences of fat distribution are different in
rodents and humans. For example, leptin exhibits a higher
expression in subcutaneous than in visceral adipose in humans
[45,46], whereas inmice leptin expression is higher in visceral fat
than in subcutaneous fat [47].
The release of adipokines has been shown to play a role in the
development of IR and has been shown to increase the risk of
obesity [7]. Among all adipokines, resistin has the highest
correlation with IR [48]. Low levels of glucose present during
periods of fasting improve glucose tolerance and increase insulin
sensitivity in resistin knockout mice [49]. An increase in resistin
levels has been described in several experimental studies using
HF diets based on saturated fatty acids [50,51]. Interestingly, we
found for the ﬁrst time an increase in resistin levels not only in
mice fed with saturated fat acids, but also in mice fed an HF diet
rich in monounsaturated fatty acids (olive oil). Moreover, the
correlation between resistin levels and visceral fat or the
adiposity index was very strong, indicating a role of the visceral
fat compartment in IR. Other studies demonstrating a causal
relation between resistin and glucose homeostasis have been
based on animal models with altered serum resistin [52]. In this
study, we also showed that IL-6 circulation was drastically
increased only in HF-L mice. IL-6 is an important component of
obesity-related IR in the liver through impairment of insulin
signaling [53,54]. IL-6 can induce IR in the liver. Senn et al. [55]
showed that IL-6 can inhibit insulin receptor signal trans-
duction in hepatocytes, indicating that IL-6 and insulin share at
least some common signal transduction pathways. In fact, we
observed a relation between IR and serum levels of IL-6 in HF-L
mice, because these mice presented the highest values of serum
insulin and HOMA-IR.
Our study showed that even in excess, polyunsaturated fatty
acids do not affect the genesis of obesity and IR. In addition, it is
interesting to note that excessive intake of monounsaturated
fatty acids had similar deleterious effects compared with a diet
rich in saturated fatty acids.
Conclusion
These results demonstrated that the type of the lipid provided
in an HF diet is more important than its quantity, especially
when considering IR, adipose tissue remodeling, and changes in
the levels of proinﬂammatory adipokines.
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